Industry Insights

31. Creating Accurate, Efficient, And Effective CDMO Project Proposals 8/15/2023

    To receive the most comprehensive project proposal possible, it is important to fill out any questionnaire as accurately and completely as possible.

32. How Upperton Has Evolved To Meet The Changing Needs Of Biotechs 3/3/2026

    CDMOs have shifted from transactional vendors to integrated scientific partners, supporting early development, regulatory strategy, advanced technologies, and faster paths from concept to clinic.

33. A Brief History Of Parenteral Process Validation — How We Got Here 6/29/2020

    Process validation has been at the center of attention of regulators and parenteral industry practitioners for years — more than 40 years to be exact. This article will look at how process validation evolved to become the primary means of ensuring consistent, high-quality production of parenterals.

34. Why Is Pharma Resistant To Digitization? 11/22/2021

    Digitizing what basically amounts to a ruled notebook into an electronic solution sounds like an easy win. It’s when you start to dig deeper that this task can quickly become burdensome, especially when presenting the proposed process map and data workflow to a steering committee.

35. Formulation, Manufacturing Capabilities For Cell & Gene Therapies 12/15/2020

    The engagement of a CDMO partner with a broad portfolio of cell and gene therapy delivery technologies, a strong formulation track record and manufacturing flexibility is the preferred pathway for success.

36. Artful Taste Masking Improves Patient Compliance 5/12/2022

    Taste masking is required for dosage forms that interact with the taste buds. Discover some of the best and most practical taste masking methods to consider for each API.

37. What Is the Current State Of BREXIT, And What Happens Next? 2/12/2020

    It's official: The United Kingdom is headed out of the European Union. Now begins a transition period, during which the trade relationship between the UK and EU will be decided, and both the European MDR and the CTR are set to take effect. 

38. Navigating AAV Vector Manufacturing

    Due to its therapeutic impact on a wide range of diseases and disorders, adeno-associated virus (AAV) gene therapy is one of the most promising advances in modern medicine.

39. In-Licensing Pharmaceutical Products: Get Technology Transfer Right 7/25/2016

    When you are looking at acquiring or in-licensing a pharmaceutical product, there are numerous technical factors that you should carefully consider, including the manufacturing and packaging process itself as well as quality control, quality assurance, regulatory affairs and logistics. Approach a new product with due diligence and a detailed checklist to ensure you leave no stone unturned.

40. The EU's Ban On TiO₂ In Food May Impact Pharma. Here's What You Should Know. 4/18/2024

    Titanium dioxide (TiO₂) is used as a food additive and OSD pharmaceutical excipient. In 2020, the European Food Safety Authority noted data gaps regarding particle size, which can affect its toxicological properties, so the European Commission banned it as a food additive. Here's how this could impact pharma.